Toyonaka, Japan

Kyoji Tomita

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyoji Tomita. Retrieved from https://idiyas.com/inventor/kyoji-tomita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyoji Tomita: Innovator in Anti-Tumor Agents

Introduction

Kyoji Tomita is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. His work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Kyoji Tomita holds 1 patent for his invention titled "Compounds, processes for the preparation thereof and anti-tumor agents." This patent reflects his innovative approach to creating effective treatments for cancer.

Career Highlights

Tomita is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His expertise in pharmaceutical sciences has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Kyoji Tomita has collaborated with esteemed colleagues such as Koh-ichiro Shibamori and Katsumi Chiba. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Kyoji Tomita's contributions to the field of anti-tumor agents exemplify the importance of innovation in healthcare. His work not only showcases his expertise but also highlights the potential for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…